Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Net Cash Flow: 2021-2024

Historic Net Cash Flow for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to $4.5 million.

  • Biofrontera's Net Cash Flow fell 144.62% to -$3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.0 million, marking a year-over-year decrease of 1227.88%. This contributed to the annual value of $4.5 million for FY2024, which is 128.56% up from last year.
  • According to the latest figures from FY2024, Biofrontera's Net Cash Flow is $4.5 million, which was up 128.56% from -$15.9 million recorded in FY2023.
  • Biofrontera's Net Cash Flow's 5-year high stood at $16.5 million during FY2021, with a 5-year trough of -$15.9 million in FY2023.
  • Over the past 3 years, Biofrontera's median Net Cash Flow value was -$7.3 million (recorded in 2022), while the average stood at -$6.2 million.
  • Per our database at Business Quant, Biofrontera's Net Cash Flow slumped by 144.55% in 2022 and then skyrocketed by 128.56% in 2024.
  • Biofrontera's Net Cash Flow (Yearly) stood at $16.5 million in 2021, then slumped by 144.55% to -$7.3 million in 2022, then plummeted by 116.36% to -$15.9 million in 2023, then skyrocketed by 128.56% to $4.5 million in 2024.